Literature DB >> 9283687

Contribution of phosphodiesterase isozymes to the regulation of the L-type calcium current in human cardiac myocytes.

K Kajimoto1, N Hagiwara, H Kasanuki, S Hosoda.   

Abstract

1. To determine the contribution of the various phosphodiesterase (PDE) isozymes to the regulation of the L-type calcium current (ICa(L)) in the human myocardium, we investigated the effect of selective and non-selective PDE inhibitors on ICa(L) in single human atrial cells by use of the whole-cell patch-clamp method. We repeated some experiments in rabbit atrial myocytes, to make a species comparison. 2. In human atrial cells, 100 microM pimobendan increased ICa(L) (evoked by depolarization to +10 mV from a holding potential of -40 mV) by 250.4 +/- 45.0% (n = 15), with the concentration for half-maximal stimulation (EC50) being 1.13 microM. ICa(L) was increased by 100 microM UD-CG 212 by 174.5 +/- 30.2% (n = 10) with an EC50 value of 1.78 microM in human atrial cells. These two agents inhibit PDE III selectively. 3. A selective PDE IV inhibitor, rolipram (1-100 microM), did not itself affect ICa(L) in human atrial cells. However, 100 microM rolipram significantly enhanced the effect of 100 microM UD-CG 212 on ICa(L) (increase with UD-CG 212 alone, 167.9 +/- 33.9, n = 5; increase with the two agents together, 270.0 +/- 52.2%; n = 5, P < 0.05). Rolipram also enhanced isoprenaline (5 nM)-stimulated ICa(L) by 52.9 +/- 9.3% (n = 5) in human atrial cells. 4. In rabbit atrial cells, ICa(L) at +10 mV was increased by 22.1 +/- 9.0% by UD-CG 212 (n = 10) and by 67.4 +/- 12.0% (n = 10) by pimobendan (each at 100 microM). These values were significantly lower than those obtained in human atrial cells (P < 0.0001). Rolipram (1-100 microM) did not itself affect ICa(L) in rabbit atrial cells. However, ICa(L) was increased by 215.7 +/- 65.2% (n = 10) by the combination of 100 microM UD-CG 212 and 100 microM rolipram. This value was almost 10 times larger than that obtained for the effect of 100 microM UD-CG 212 alone. 5. These results imply a species difference: in the human atrium, the PDE III isoform seems dominant, whereas PDE IV may be more important in the rabbit atrium for regulating ICa(L). However, PDE IV might contribute significantly to the regulation of intracellular cyclic AMP in human myocardium when PDE III is already inhibited or when the myocardium is under beta-adrenoceptor-mediated stimulation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9283687      PMCID: PMC1564856          DOI: 10.1038/sj.bjp.0701297

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  15 in total

1.  Effects of propafenone on K currents in human atrial myocytes.

Authors:  A Seki; N Hagiwara; H Kasanuki
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

2.  The cardiac IKs potassium channel macromolecular complex includes the phosphodiesterase PDE4D3.

Authors:  Cecile Terrenoire; Miles D Houslay; George S Baillie; Robert S Kass
Journal:  J Biol Chem       Date:  2009-02-13       Impact factor: 5.157

3.  Basal Spontaneous Firing of Rabbit Sinoatrial Node Cells Is Regulated by Dual Activation of PDEs (Phosphodiesterases) 3 and 4.

Authors:  Tatiana M Vinogradova; Syevda Sirenko; Yevgeniya O Lukyanenko; Dongmei Yang; Kirill V Tarasov; Alexey E Lyashkov; Nevin J Varghese; Yue Li; Khalid Chakir; Bruce Ziman; Edward G Lakatta
Journal:  Circ Arrhythm Electrophysiol       Date:  2018-06

4.  Message delivered: how myocytes control cAMP signaling.

Authors:  David A Kass
Journal:  Circ Res       Date:  2008-05-09       Impact factor: 17.367

5.  Phosphodiesterase 4B in the cardiac L-type Ca²⁺ channel complex regulates Ca²⁺ current and protects against ventricular arrhythmias in mice.

Authors:  Jérôme Leroy; Wito Richter; Delphine Mika; Liliana R V Castro; Aniella Abi-Gerges; Moses Xie; Colleen Scheitrum; Florence Lefebvre; Julia Schittl; Philippe Mateo; Ruth Westenbroek; William A Catterall; Flavien Charpentier; Marco Conti; Rodolphe Fischmeister; Grégoire Vandecasteele
Journal:  J Clin Invest       Date:  2011-06-13       Impact factor: 14.808

6.  Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.

Authors:  I Verde; G Vandecasteele; F Lezoualc'h; R Fischmeister
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

7.  Cilostamide potentiates more the positive inotropic effects of (-)-adrenaline through beta(2)-adrenoceptors than the effects of (-)-noradrenaline through beta (1)-adrenoceptors in human atrial myocardium.

Authors:  T Christ; A Engel; U Ravens; A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-11-15       Impact factor: 3.000

8.  Inhibition of cyclic GMP hydrolysis with zaprinast reduces basal and cyclic AMP-elevated L-type calcium current in guinea-pig ventricular myocytes.

Authors:  Mark T Ziolo; Susanne J Lewandowski; Jacquelyn M Smith; Fred D Romano; Gordon M Wahler
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

9.  PDE4 in the human heart - major player or little helper?

Authors:  Thomas Eschenhagen
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

10.  Differential regulation of cardiac excitation-contraction coupling by cAMP phosphodiesterase subtypes.

Authors:  Delphine Mika; Pierre Bobin; Martine Pomérance; Patrick Lechêne; Ruth E Westenbroek; William A Catterall; Grégoire Vandecasteele; Jérôme Leroy; Rodolphe Fischmeister
Journal:  Cardiovasc Res       Date:  2013-08-09       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.